Distinct Patterns of Transforming Growth Factor-β Isoform and Receptor Expression in Human Atherosclerotic Lesions: Colocalization Implicates TGF-β in Fibrofatty Lesion Development
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background —Some animal studies suggest that transforming growth factor-β (TGF-β) protects vessels from atherosclerosis by preventing intima formation, but others indicate a role in vessel proteoglycan accumulation and lipoprotein retention. To distinguish between these possibilities in humans, immunohistochemical studies were performed examining the coexpression of TGF-β isoforms and the TGF-β receptors ALK-5 and TβR-II in aorta during the various stages of atherosclerotic lesion development. Methods and Results —The spatial relationships between TGF-β 1 , TGF-β 3 , ALK-5, and TβR-II expression were compared in aortic segments from 21 subjects. Nonatherosclerotic intima contained predominantly TGF-β 1 , low concentrations of TβR-II, and barely detectable amounts of ALK-5. In contrast, fatty streaks/fibrofatty lesions contained high concentrations of both TGF-β isoforms. Smooth muscle cells (SMCs), macrophages, and foam cells of macrophage and SMC origin contributed to these high levels. These lesions also contained high, colocalized concentrations of ALK-5 and TβR-II. Despite fibrous plaques containing TGF-β 1 , its receptors were at detection limits. We found no evidence for truncated TβR-II expression in either normal intima or the various atherosclerotic lesions. Conclusions —TGF-β appears to be most active in lipid-rich aortic intimal lesions. The findings support the hypothesis that TGF-β contributes primarily to the pathogenesis of lipid-rich atherosclerotic lesions by stimulating the production of lipoprotein-trapping proteoglycans, inhibiting smooth muscle proliferation, and activating proteolytic mechanisms in macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cited by
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Bone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,049
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Tyson, K. L., Reynolds, J. L., McNair, R., Zhang, Q., Weissberg, P. L., & Shanahan, C. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059406.92165.31 · Cited by 523
Mallat, Z., Gojova, A., Marchiol-Fournigault, C., Esposito, B., Kamaté, C., Merval, R., Fradelizi, D., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh2201.099415 · Cited by 490
Adela, R., & Banerjee, S. K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/490842 · Cited by 474
Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., & Daemen, M. J. A. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000019729.39500.2f · Cited by 313
Nakashima, Y., Wight, T. N., & Sueishi, K. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn099 · Cited by 299
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7464 · Cited by 271
Transforming Growth Factor-βs and Vascular Disorders
Bobik, A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000225287.20034.2c · Cited by 258
Self-citationSchlittenhardt, D., Schober, A., Strelau, J., Bonaterra, G. A., Schmiedt, W., Unsicker, K., Metz, J., & Kinscherf, R. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0986-3 · Cited by 224
“Several earlier studies report that many members of the TGF-β superfamily are involved in inflammatory processes, such as those in arteriosclerotic lesions (Corradin et al. 1993; Letterio and Roberts 1998; Bobik et al. 1999; Reckless et al. 2001).”
BackgroundToma, I., & McCaffrey, T. A. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1189-3 · Cited by 193
“Expression of the TβR-1 (Alk5) and TβR-2 is elevated in the early fibro-fatty streak (Bobik et al. 1999).”
InfluentialInsights into bone morphogenetic proteins in cardiovascular diseases
Ye, D., Liu, Y., Pan, H., Feng, Y., Lu, X., Gan, L., Wan, J., & Ye, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125642 · Cited by 37
“It has been reported that the expression of TGF-β ligands, receptors and phosphorylated SMAD2/3 are increased in human atherosclerotic lesions (Bobik et al., 1999; Frostegard et al., 1999; Kalinina et al., 2004).”
Background
Metadata
- Authors
- Bobik, A., Agrotis, A., Kanellakis, P., Dilley, R., Krushinsky, A., Smirnov, V., Tararak, E., Condron, M., & Kostolias, G.
- Venue
- Circulation
- Published
- 1999-06-08
- Volume
- 99
- Issue
- 22
- Pages
- 2883-2891
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2035704867
- Cited by
- 157
- References
- 1
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.